- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03369288
Assessing Cement-bone Incorporation and Adjacent Segment Degeneration Following Cement Augmentation; an MRI-PET Follow-up
October 29, 2018 updated by: University of Zurich
3-year PET-MRI follow-up after vertebral balloon kyphoplasty aiming to investigate cement incorporation.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Georg Osterhoff, MD
- Phone Number: 0041 44 255 11 11
- Email: georg.osterhoff@usz.ch
Study Locations
-
-
-
Zürich, Switzerland, 8091
- Recruiting
- Division of Trauma Surgery, University Hospital Zurich
-
Contact:
- Georg Osterhoff, MD
- Phone Number: +41 44 255 1111
- Email: georg.osterhoff@usz.ch
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion criteria
- Men and women aged 18 to 70 years
- Minimum 3-year follow-up
- Single-level vertebral kyphoplasty
- Index surgery at UniversitätsSpital Zürich
- MRI-scan during initial treatment
- Informed consent provided
Exclusion criteria
- Combined with other operative procedure on the spine (e.g. dorsal instrumentation)
- Intraoperative intradiscal cement leakage
- Previous history of spinal surgery except on the cervical spine
- Metastatic disease with skeletal involvement
- Known chronic diseases of the bone metabolism other than osteoporosis
- Documented pregnancy (see also 6.3)
- Presence of implants not suited for MRI (pacemaker, neuro-stimulators, pain pumps, insulin pumps, Cochlea implants, metallic foreign bodies like bullet fragments)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Tracer Uptake
Time Frame: at least 3 years after kyphoplasty
|
Perifokal tracer uptake at the cement-bone border
|
at least 3 years after kyphoplasty
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intravertebral Discs
Time Frame: at least 3 years after kyphoplasty
|
Tracer uptake within the intravertebral disc and morphological changes
|
at least 3 years after kyphoplasty
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 5, 2017
Primary Completion (Anticipated)
June 28, 2019
Study Completion (Anticipated)
November 28, 2019
Study Registration Dates
First Submitted
December 5, 2017
First Submitted That Met QC Criteria
December 5, 2017
First Posted (Actual)
December 11, 2017
Study Record Updates
Last Update Posted (Actual)
October 30, 2018
Last Update Submitted That Met QC Criteria
October 29, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017-01207
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vertebral Fracture
-
AgNovos Healthcare, LLCRecruitingVertebral Fracture | Vertebral Compression Fracture | Vertebral CompressionGermany, Spain
-
AgNovos Healthcare, LLCRecruitingVertebral Compression Fracture | Vertebral Compression | Compression FractureUnited States
-
University of Texas Southwestern Medical CenterMedtronicCompletedLumbar Vertebral FractureUnited States
-
Optimus Clinical ResearchCareFusionCompletedVertebral Compression Fractures | Osteoporotic Vertebral Compression Fractures | Acute Vertebral FracturesAustralia
-
University Hospital, Clermont-FerrandCompletedVertebrOpLasty Versus Conservative Treatment in Acute Non Osteoporotic Vertebral Fractures (VOLCANO)Vertebral Compression Fracture | Spinal TraumaFrance
-
Icahn School of Medicine at Mount SinaiRecruitingVertebral Compression Fractures | Osteoporotic Vertebral Compression FracturesUnited States
-
Jaseng Medical FoundationRecruitingVertebral Compression Fracture | Vertebral Compression | Korean Traditional Medicine | Integrative Korean MedicineKorea, Republic of
-
Hospital for Special Surgery, New YorkCompletedVertebral Compression FractureUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingPrediction Model | Osteoporotic Vertebral FractureChina
-
Northwell HealthCompletedVertebral Fracture | Vertebral Compression | Vertebra Compression FractureUnited States
Clinical Trials on PET MRI
-
Cambridge University Hospitals NHS Foundation TrustRecruitingBreast CancerUnited Kingdom
-
Maastricht University Medical CenterCompletedOvarian NeoplasmsNetherlands
-
Jeffrey A. Lieberman, MDTerminated
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH)TerminatedSchizophreniaUnited States
-
Università Vita-Salute San RaffaeleIRCCS San Raffaele; Associazione Italiana per la Ricerca sul CancroNot yet recruitingBreast Cancer Female | Lobular Breast Carcinoma | Luminal A Breast Cancer | PET/MRI | Axillary Lymphadenopathy
-
University of EdinburghActive, not recruiting
-
NYU Langone HealthDendreonTerminatedProstate CancerUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI)Terminated
-
Massachusetts General HospitalRecruiting
-
Xuzhou Medical UniversityUnknownProstate Cancer